Package 31722-183-05

{"route": ["ORAL"], "spl_id": "62911647-4208-47b3-a9af-67f026411019", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0331722183055", "0331722182058", "0331722183604", "0331722181600", "0331722181051", "0331722182607", "0331722184052", "0331722184601"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["cefbc5f4-ef5f-4732-ab96-a69a183f0b6b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (31722-183-05)", "package_ndc": "31722-183-05", "marketing_start_date": "20210922"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (31722-183-60)", "package_ndc": "31722-183-60", "marketing_start_date": "20210922"}], "brand_name": "TOPIRAMATE", "product_id": "31722-183_62911647-4208-47b3-a9af-67f026411019", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "31722-183", "generic_name": "Topiramate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOPIRAMATE", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA215414", "marketing_category": "ANDA", "marketing_start_date": "20210922", "listing_expiration_date": "20261231"}